Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Account Payables (2017 - 2020)

Fortress Biotech (FBIO) has 5 years of Change in Account Payables data on record, last reported at -$19000.0 in Q4 2020.

  • For Q4 2020, Change in Account Payables changed N/A year-over-year to -$19000.0; the TTM value through Mar 2021 reached -$6000.0, up 97.77%, while the annual FY2019 figure was -$149000.0, 547.83% down from the prior year.
  • Change in Account Payables reached -$19000.0 in Q4 2020 per FBIO's latest filing, down from $13000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $133000.0 in Q1 2019 and bottomed at -$298000.0 in Q3 2019.
  • Average Change in Account Payables over 4 years is -$15400.0, with a median of $6000.0 recorded in 2018.
  • The widest YoY moves for Change in Account Payables: up 1700.0% in 2019, down 472.5% in 2019.
  • A 4-year view of Change in Account Payables shows it stood at $24000.0 in 2017, then plummeted by 116.67% to -$4000.0 in 2018, then tumbled by 7350.0% to -$298000.0 in 2019, then soared by 93.62% to -$19000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were -$19000.0 in Q4 2020, $13000.0 in Q1 2020, and -$298000.0 in Q3 2019.